Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

AGM Statement

24 Apr 2008 07:01

Persimmon PLC24 April 2008 AGM STATEMENT THURSDAY 24TH APRIL 2008 Persimmon plc is holding its Annual General Meeting at 12 noon today at YorkRacecourse where the following comments will be made regarding current trading,financial performance and the outlook for the financial year. This statementcovers the period from 1st January 2008 to the date of this announcement andconstitutes Persimmon plc's first Interim Management Statement as required bythe UK Listing Authority's Disclosure and Transparency Rules. When we announced our results for the year ended 31st December 2007 on 25thFebruary 2008, we commented that purchasers were applying a "wait and see"approach to house purchases. During March, visitor levels to our sites were encouraging, although salesreservation volumes remained flat and cancellation rates continued at normallevels. However, over the last three weeks the unprecedented tightening in the mortgagemarket has caused a further deterioration of the housing market leading to lowersales volumes and increased cancellation rates. At the same time the backdropof extensively reported concerns about the global credit crisis have continuedto undermine consumer confidence. As a result an increase in discounting, marketing costs and incentives are beingutilised in the market to compete for the reduced level of demand and this ishaving a negative impact on margins. Whilst we continue to focus on achievingthe best possible selling price in every location it is likely that, with thecontinuation of current conditions, the market will become more challenging. Total sales revenue for 2008 is currently c. £1.37 billion compared to c. £1.80billion last year, a decrease of 24%. Volumes are down less, by c. 18% due toan increase in the amount of partnership homes we are building. We welcome the recent Government actions being taken to increase liquidity inthe banking system with the key objective of kick starting the mortgage market.For this action to be effective it needs to result in an increase in theavailability of credit for house purchasers, particularly first time buyers. Webelieve that the Government should urgently consider additional action tobenefit first time buyers by increasing the threshold for stamp duty to supportan improvement in activity and help those who are most in need of assistance.Further reductions in interest rates would also be helpful in supportingsentiment. Because of the uncertainties of the global economy and the UK lendingenvironment it is difficult to predict when the market will improve. We aretherefore focusing on management of cash flows within the business to ensurethat our balance sheet strength is maintained. Close control of investments inwork in progress, land, build costs and overheads are a priority for ourexperienced management teams. We are currently operating off c. 5% more sitesthan a year ago. Against the current backdrop we have postponed thecommencement of scheduled new sites until the mortgage market improves. At theend of March, our borrowings were £1.03 billion. Our committed facilities whichhave an average term to maturity of over 3 years provides comfortable headroomfor our seasonal peak debt requirements in April. Two years ago, in April 2006 John White became Chairman of the Group and at thesame time Mike Farley was promoted to Group Chief Executive. It was agreed bythe Board that for a transitional period, in addition to fulfilling the normalrole of Chairman, John would provide additional support to the Group as thesignificant acquisition of Westbury plc was integrated into the business. Withthe integration period successfully completed John White will now continue asGroup Chairman with the standard responsibilities that role implies. At some stage, in our view, housing market activity will improve given theunderlying requirement for more housing and a "place to live" in the UK. Givenour strong financial position and scale we remain confident in the medium andlong term prospects for Persimmon. For further information, please contact: Persimmon plc Tel: +44 1904 642 199 John White, Group ChairmanMike Farley, Group Chief ExecutiveMike Killoran, Group Finance Director M:Communications Ed Orlebar:+44 (0)20 7153 1523 / +44 (0)7738 724 630orlebar@mcomgroup.com Charlotte McMullen: +44 (0)20 7153 1549 / +44 (0)7921 881 800mcmullen@mcomgroup.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.